Nora Therapeutics to Present at Upcoming Conferences in February - AZTV7/Cable 13, Me-TV 7.2, HSN 7.3, Phoenix-Prescott, AZ

Nora Therapeutics to Present at Upcoming Conferences in February

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Nora Therapeutics

PALO ALTO, Calif., Feb. 5, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the following conferences in February:

  • 16th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York on Tuesday, Feb. 11, 2014 at 8:45 a.m. (EST).
  • Leerink Global Healthcare Conference 2014 at the Waldorf Astoria in New York on Wednesday, Feb. 12, 2014 at 8:25 a.m. (EST).

About Nora Therapeutics, Inc.
Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions with significant unmet need. Nora's lead compound, NT100, is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract and may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information, please visit our website at www.noratherapeutics.com.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and AZ-TV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.